Certified by Founder Lodge
Verismo Therapeutics
United States - Philadelphia, Pennsylvania
START UP
1 Disclosed Funding Rounds $7,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Verismo Therapeutics is pioneering the development of novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer, especially non-hematologic malignanc
Date | Round | Raised | Participating Investors |
---|---|---|---|
March, 01 ,2023 | Pre Series A | $7,000,000 | |
July, 19 ,2023 | Seed | $6,000,000 |